RECURRENT GLIOBLASTOMA IDH WILDTYPE
Clinical trials for RECURRENT GLIOBLASTOMA IDH WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOBLASTOMA IDH WILDTYPE trials appear
Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA IDH WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested in fight against deadly brain cancer
Disease control TerminatedThis study is testing a new two-part treatment for aggressive brain tumors that have returned or worsened. It aims to see if giving the drugs GI-102 and pembrolizumab just before surgery is safe and can help the immune system attack the tumor. The trial is for adults with specifi…
Matched conditions: RECURRENT GLIOBLASTOMA IDH WILDTYPE
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope for fighting back against aggressive brain tumors
Disease control TerminatedThis study is testing whether adding a new drug called selinexor to standard chemotherapy (temozolomide) works better than the standard chemotherapy alone for glioblastoma brain cancer that has returned. The trial first finds the safest dose of the combination, then compares how …
Matched conditions: RECURRENT GLIOBLASTOMA IDH WILDTYPE
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Early trial aims to halt return of aggressive brain tumors
Disease control OngoingThis early-stage study is testing a new drug combination for adults whose aggressive brain cancer (glioblastoma) has returned. Researchers want to find the safest and most effective dose of an experimental drug called triapine when given with the standard chemotherapy temozolomid…
Matched conditions: RECURRENT GLIOBLASTOMA IDH WILDTYPE
Phase: PHASE1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC